Search Results 1891-1900 of 18829 for Relapse
A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma ...
Other malignancy unless disease-free for ≥ 2 years and not expected to relapse or require treatment during study participation. Active systemic infection ...
The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
"We switched to a second-line treatment program that resulted in a brief improvement, but he again relapsed," Dr. Johnson says. Dr. Johnson then discussed ...
... relapse will improve disease-free survival (DFS). Risk stratification will be determined by traditional prognosticators (tumor genetics, extent of ...
... (relapsed/refractory patients; patients must have failed at least one prior line of therapy) or for whom there is no effective standard therapy based on the ...
... Relapse in Subjects with Substance Use Disorders Rochester, MN. Impulsivity is a major component of addictive behavior contributing to the initiation and ...
Sticking with the program also can reduce relapses. Be encouraging and positive. As you help your child overcome encopresis, be patient and use positive ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.